A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for Graves' Disease
Drug: IMVT-1402
Sites in Metairie, New Orleans +56 more locations
Sponsor: Immunovant Sciences GmbH
Sex: All·Age: 18 - 75
Code: NCT06727604·Phase 2·Recruiting·Listed Dec 2024